HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laila Asmal Selected Research

flupenthixol decanoate (Depixol)

1/2022The trajectories and correlates of two negative symptom subdomains in first-episode schizophrenia.
1/2021Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate.
1/2021Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate.
1/2021Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia.
12/2019Prolactin, flupenthixol decanoate and first episode schizophrenia - clinical and laboratory correlates.
2/2016Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.
8/2015Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.
5/2015Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laila Asmal Research Topics

Disease

29Schizophrenia (Dementia Praecox)
11/2022 - 08/2013
6Psychotic Disorders (Schizoaffective Disorder)
11/2020 - 08/2013
3Substance-Related Disorders (Drug Abuse)
01/2021 - 01/2021
2Body Weight (Weight, Body)
08/2015 - 11/2013
1Cognitive Dysfunction
11/2022
1Hyperprolactinemia
12/2019
1Tardive Dyskinesia
01/2018
1Psychomotor Agitation (Akathisia)
01/2018
1Obesity
01/2016
1Mood Disorders (Mood Disorder)
05/2015
1Movement Disorders (Movement Disorder)
11/2013
1Weight Gain
11/2013

Drug/Important Bio-Agent (IBA)

23Antipsychotic Agents (Antipsychotics)IBA
09/2021 - 08/2013
8flupenthixol decanoate (Depixol)IBA
01/2022 - 05/2015
2ProlactinIBA
12/2019 - 11/2013
2Pharmaceutical PreparationsIBA
05/2016 - 11/2013
2Risperidone (Risperdal Consta)FDA LinkGeneric
08/2015 - 11/2013
1Methamphetamine (Desoxyn)FDA LinkGeneric
11/2022
1Dopamine (Intropin)FDA LinkGeneric
09/2021
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2021
1Polytetrafluoroethylene (Teflon)FDA Link
12/2019
1Flupenthixol (Flupentixol)IBA
12/2019
1Adenosine Monophosphate (AMP)IBA
02/2016
1LeptinIBA
01/2016
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2016
1Leptin ReceptorsIBA
01/2016
1Serotonin ReceptorsIBA
01/2016
1AntioxidantsIBA
09/2014
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
09/2014
1Thioctic Acid (Lipoic Acid)IBA
09/2014
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
09/2014
1Glucose (Dextrose)FDA LinkGeneric
11/2013
1Clozapine (Clozaril)FDA LinkGeneric
11/2013
1CholesterolIBA
11/2013
1ziprasidone (Geodon)FDA Link
11/2013
1Olanzapine (Zyprexa)FDA Link
11/2013
1Quetiapine Fumarate (Seroquel)FDA Link
11/2013
1Paliperidone PalmitateFDA Link
11/2013
1Aripiprazole (Abilify)FDA Link
11/2013

Therapy/Procedure

6Injections
01/2022 - 08/2013
1Treatment Delay
01/2021
1Cognitive Training
01/2017
1Secondary Prevention
09/2014
1Drug Therapy (Chemotherapy)
06/2014